CCR5 Receptor Occupancy Analysis Reveals Increased Peripheral Blood CCR5+CD4+ T Cells Following Treatment With the Anti-CCR5 Antibody Leronlimab is a research paper published in Frontiers in Immunology (2021). On theSindex it has a DataRank of 1.1. It has been cited 26 times, with 16 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.494
From this paper's citation signal
Citation Network Contribution
0.628
From 14 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 16 citers.
Division of Intramural Research, National Institute of Allergy and Infectious Diseases
Grant: AI129703, R01 AI54559, R21 AI54559
National Institutes of Health
Grant: P51 OD011092
NIAID NIH HHS
Grant: R01 AI129703
NIAID NIH HHS
Grant: R01 AI175459
NIAID NIH HHS
Grant: R01 AI154559
National Institutes of Health
Grant: 3P51OD011092-55S1
SUPPORT FOR NATIONAL PRIMATE RESEARCH CENTER
National Institutes of Health
Grant: 2R01AI129703-06A1
A nonhuman primate model of stem cell transplantation to understand determinants of post-transplant SIV clearance
FWCI
2.48
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of CT-based machine learning radiomics predicts CCR5 expression level and survival in ovarian cancer
Additional file 1 of CT-based machine learning radiomics predicts CCR5 expression level and survival in ovarian cancer